256 related articles for article (PubMed ID: 11076674)
1. E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis.
Jiang Z; Liang P; Leng R; Guo Z; Liu Y; Liu X; Bubnic S; Keating A; Murray D; Goss P; Zacksenhaus E
Dev Biol; 2000 Nov; 227(1):8-41. PubMed ID: 11076674
[TBL] [Abstract][Full Text] [Related]
2. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
3. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
4. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR
Oncogene; 1998 May; 16(19):2489-501. PubMed ID: 9627115
[TBL] [Abstract][Full Text] [Related]
5. Small contribution of G1 checkpoint control manipulation to modulation of p53-mediated apoptosis.
Canman CE; Kastan MB
Oncogene; 1998 Feb; 16(8):957-66. PubMed ID: 9519869
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis.
Guo Z; Yikang S; Yoshida H; Mak TW; Zacksenhaus E
Cancer Res; 2001 Dec; 61(23):8395-400. PubMed ID: 11731416
[TBL] [Abstract][Full Text] [Related]
7. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
8. Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity.
Callaghan DA; Dong L; Callaghan SM; Hou YX; Dagnino L; Slack RS
Dev Biol; 1999 Mar; 207(2):257-70. PubMed ID: 10068462
[TBL] [Abstract][Full Text] [Related]
9. Expression of a deletion mutant of the E2F1 transcription factor in fibroblasts lengthens S phase and increases sensitivity to S phase-specific toxins.
Logan TJ; Evans DL; Mercer WE; Bjornsti MA; Hall DJ
Cancer Res; 1995 Jul; 55(13):2883-91. PubMed ID: 7540951
[TBL] [Abstract][Full Text] [Related]
10. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP
Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor proteins as regulators of cell differentiation.
Li ZR; Hromchak R; Mudipalli A; Bloch A
Cancer Res; 1998 Oct; 58(19):4282-7. PubMed ID: 9766653
[TBL] [Abstract][Full Text] [Related]
12. MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.
Peschiaroli A; Figliola R; Coltella L; Strom A; Valentini A; D'Agnano I; Maione R
Oncogene; 2002 Nov; 21(53):8114-27. PubMed ID: 12444547
[TBL] [Abstract][Full Text] [Related]
13. p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas.
Divan A; Lawry J; Dunsmore IR; Parsons MA; Royds JA
Cancer Res; 2001 Apr; 61(7):3157-63. PubMed ID: 11306502
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1.
Wang J; Helin K; Jin P; Nadal-Ginard B
Cell Growth Differ; 1995 Oct; 6(10):1299-306. PubMed ID: 8845307
[TBL] [Abstract][Full Text] [Related]
15. The proliferative and apoptotic activities of E2F1 in the mouse retina.
Lin SC; Skapek SX; Papermaster DS; Hankin M; Lee EY
Oncogene; 2001 Oct; 20(48):7073-84. PubMed ID: 11704831
[TBL] [Abstract][Full Text] [Related]
16. MyoD activity upregulates E2F1 and enhances transcription from the cyclin E promoter in differentiating myoblasts lacking a functional retinoblastoma protein.
Tedesco D; Vesco C
Exp Cell Res; 2001 Oct; 269(2):301-11. PubMed ID: 11570822
[TBL] [Abstract][Full Text] [Related]
17. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells.
Gorospe M; Cirielli C; Wang X; Seth P; Capogrossi MC; Holbrook NJ
Oncogene; 1997 Feb; 14(8):929-35. PubMed ID: 9050992
[TBL] [Abstract][Full Text] [Related]
18. Differential post-translational modification of the tumour suppressor proteins Rb and p53 modulate the rates of radiation-induced apoptosis in vivo.
Wallace M; Coates PJ; Wright EG; Ball KL
Oncogene; 2001 Jun; 20(28):3597-608. PubMed ID: 11439323
[TBL] [Abstract][Full Text] [Related]
19. Alterations in expression of E2F-1 and E2F-responsive genes by RB, p53 and p21(Sdi1/WAF1/Cip1) expression.
Ookawa K; Tsuchida S; Kohno T; Yokota J
FEBS Lett; 2001 Jun; 500(1-2):25-30. PubMed ID: 11434920
[TBL] [Abstract][Full Text] [Related]
20. RB regulates transcription of the p21/WAF1/CIP1 gene.
Decesse JT; Medjkane S; Datto MB; Crémisi CE
Oncogene; 2001 Feb; 20(8):962-71. PubMed ID: 11314031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]